{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:39:45Z","timestamp":1780097985515,"version":"3.54.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jacbts.2026.101508","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:57:15Z","timestamp":1774292235000},"page":"101508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["RIG-I\u2013Adjuvanted Immunogen Elicited T-Cell Immunity Controls Trypanosoma cruzi, Chagasic Cardiomyopathy, and Left Ventricular Dysfunction"],"prefix":"10.1016","volume":"11","author":[{"given":"Nandadeva","family":"Lokugamage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Wyrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhadip","family":"Choudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran H.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upendra","family":"Marathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3453-2369","authenticated-orcid":false,"given":"Nisha Jain","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2026.101508_bib1","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3201\/eid3109.241700","article-title":"Chagas disease, an endemic disease in the United States","volume":"31","author":"Beatty","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jacbts.2026.101508_bib2","article-title":"Chagas disease in Europe","volume":"8","author":"Gonzalez-Sanz","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.jacbts.2026.101508_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-pathol-020117-043711","article-title":"Pathology and pathogenesis of Chagas heart disease","volume":"14","author":"Bonney","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jacbts.2026.101508_bib4","article-title":"Clinical features of Chagas disease progression and severity","volume":"37","author":"Nunes","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.jacbts.2026.101508_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","article-title":"Global economic burden of Chagas disease: a computational simulation model","volume":"13","author":"Lee","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jacbts.2026.101508_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007668","article-title":"Longitudinal follow up of serological response in children treated for Chagas disease","volume":"13","author":"Moscatelli","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jacbts.2026.101508_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01135-20","article-title":"Adverse events associated with nifurtimox treatment for Chagas disease in children and adults","volume":"65","author":"Berenstein","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jacbts.2026.101508_bib9","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1111\/bcp.16214","article-title":"Adverse events associated with benznidazole treatment for Chagas disease in children and adults","volume":"90","author":"Cruz","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacbts.2026.101508_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13071-023-05775-4","article-title":"Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations","volume":"16","author":"Lima","year":"2023","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.jacbts.2026.101508_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1244071","article-title":"Immunopathogenesis in Trypanosoma cruzi infection: a role for suppressed macrophages and apoptotic cells","volume":"14","author":"Vellozo","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacbts.2026.101508_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-2478(00)00205-4","article-title":"CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism","volume":"73","author":"Rodrigues","year":"2000","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jacbts.2026.101508_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/IAI.68.1.197-204.2000","article-title":"Involvement of CD4+ Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi","volume":"68","author":"Hoft","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.jacbts.2026.101508_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.pt.2020.08.001","article-title":"\u03b1-Gal-based vaccines: advances, opportunities, and perspectives","volume":"36","author":"Hod\u017ei\u0107","year":"2020","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jacbts.2026.101508_bib15","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.158.7.3293","article-title":"Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway","volume":"158","author":"Garg","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jacbts.2026.101508_bib16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.pt.2019.08.006","article-title":"Understanding CD8+T cell immunity to Trypanosoma cruzi and how to improve it","volume":"35","author":"Acosta Rodr\u00edguez","year":"2019","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jacbts.2026.101508_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.100972","article-title":"Challenges and advancements in the development of vaccines and therapies against Chagas disease","volume":"5","author":"Pinazo","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jacbts.2026.101508_bib18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/pathogens14020124","article-title":"An Update on vaccines against Trypanosoma cruzi and Chagas disease","volume":"14","author":"Garg","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.jacbts.2026.101508_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/178947","article-title":"Immune evasion strategies of Trypanosoma cruzi","volume":"2015","author":"Fl\u00e1via Nardy","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jacbts.2026.101508_bib20","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1128\/IAI.72.11.6245-6254.2004","article-title":"Utility of Trypanosoma cruzi sequence database for the identification of potential vaccine candidates: In silico and in vitro screening","volume":"72","author":"Bhatia","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.jacbts.2026.101508_bib21","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/CVI.00144-08","article-title":"Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice","volume":"15","author":"Bhatia","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jacbts.2026.101508_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000797","article-title":"Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice","volume":"4","author":"Gupta","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jacbts.2026.101508_bib23","first-page":"1464","article-title":"Delivery of antigenic candidates by a DNA\/MVA heterologous approach elicits effector CD8+T cell mediated immunity against Trypanosoma cruzi","volume":"12","author":"Gupta","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jacbts.2026.101508_bib24","article-title":"A two-component DNA-prime\/protein-boost vaccination strategy for eliciting long-term, protective T cell immunity against","volume":"11","author":"Gupta","year":"2015","journal-title":"Trypanosoma cruzi. PLoS Pathog"},{"key":"10.1016\/j.jacbts.2026.101508_bib25","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3389\/fimmu.2019.01456","article-title":"TcG2\/TcG4 DNA vaccine induces Th1 immunity against acute Trypanosoma cruzi infection: adjuvant and antigenic effects of heterologous T. rangeli booster immunization","volume":"10","author":"Gupta","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacbts.2026.101508_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.595039","article-title":"Experimental nanovaccine offers protection against repeat exposures to Trypanosoma cruzi through activation of polyfunctional T cell response","volume":"11","author":"Chowdhury","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacbts.2026.101508_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41541-021-00378-5","article-title":"Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease","volume":"6","author":"Lokugamage","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jacbts.2026.101508_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/vaccines8010096","article-title":"Antigen-based nano-immunotherapy controls parasite persistence, inflammatory and oxidative Stress, and cardiac fibrosis, the hallmarks of chronic Chagas cardiomyopathy, in a mouse model of Trypanosoma cruzi infection","volume":"8","author":"Lokugamage","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.jacbts.2026.101508_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001050","article-title":"Testing the efficacy of a multi-component DNA-prime\/DNA-boost vaccine against Trypanosoma cruzi infection in dogs","volume":"5","author":"Aparicio-Burgos","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jacbts.2026.101508_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003625","article-title":"Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model","volume":"9","author":"Aparicio-Burgos","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jacbts.2026.101508_bib31","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41598-017-02460-2","article-title":"Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2026.101508_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/156652321403140819122538","article-title":"Improving DNA vaccine performance through vector design","volume":"14","author":"Williams","year":"2014","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.jacbts.2026.101508_bib34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/bit.22936","article-title":"Plasmid DNA fermentation strain and process-specific effects on vector yield, quality, and transgene expression","volume":"108","author":"Carnes","year":"2011","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.jacbts.2026.101508_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jacbts.2016.04.005","article-title":"Chemotherapeutic efficacy of phosphodiesterase inhibitors in chagasic cardiomyopathy","volume":"1","author":"Wen","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacbts.2026.101508_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165706","article-title":"Interleukin-17 mediated immunity during infections with Trypanosoma cruzi and other protozoans","volume":"1866","author":"Amezcua Vesely","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jacbts.2026.101508_bib38","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1016\/j.vaccine.2021.05.039","article-title":"Antibodies response induced by recombinant virus-like particles from Triatoma virus and chimeric antigens from Trypanosoma cruzi","volume":"39","author":"Queiroz","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jacbts.2026.101508_bib39","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(22)00524-4","article-title":"DNA vaccines join the fight against COVID-19","volume":"399","author":"Blakney","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2026.101508_bib40","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.ymthe.2025.04.008","article-title":"DNA-based immunotherapy for cancer: In vivo approaches for recalcitrant targets","volume":"33","author":"Bhojnagarwala","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacbts.2026.101508_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2019.105168","article-title":"Immunity and vaccine development efforts against Trypanosoma cruzi","volume":"200","author":"Rios","year":"2019","journal-title":"Acta Trop"},{"key":"10.1016\/j.jacbts.2026.101508_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41541-017-0010-z","article-title":"Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi","volume":"2","author":"Sanchez-Alberti","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jacbts.2026.101508_bib43","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.omtm.2020.04.009","article-title":"Nanoplasmid vectors co-expressing innate immune agonists enhance DNA vaccines for Venezuelan equine encephalitis virus and Ebola virus","volume":"17","author":"Suschak","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jacbts.2026.101508_bib44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s42003-023-04812-3","article-title":"Human CD4 cytotoxic T lymphocytes mediate potent tumor control in humanized immune system mice","volume":"6","author":"Lin","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.jacbts.2026.101508_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1271236","article-title":"Cytotoxic CD4+T cells in chronic viral infections and cancer","volume":"14","author":"Malyshkina","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacbts.2026.101508_bib46","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.freeradbiomed.2023.12.024","article-title":"Superoxide, nitric oxide and peroxynitrite production by macrophages under different physiological oxygen tensions","volume":"212","author":"Casella","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jacbts.2026.101508_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2023.102770","article-title":"Oxidative stress evaluation in patients with chronic Chagas disease","volume":"96","author":"de Carvalho","year":"2023","journal-title":"Parasitol Internatl"},{"key":"10.1016\/j.jacbts.2026.101508_bib48","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/IAI.01931-06","article-title":"Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease","volume":"75","author":"Souza","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.jacbts.2026.101508_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002364","article-title":"Innate immune responses and antioxidant\/oxidant imbalance are major determinants of human Chagas disease","volume":"7","author":"Dhiman","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jacbts.2026.101508_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1338582","article-title":"Correlation of blood-based immune molecules with cardiac gene expression profiles reveals insights into Chagas cardiomyopathy pathogenesis","volume":"15","author":"Souza-Silva","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacbts.2026.101508_bib51","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/pim.12183","article-title":"IL-10 and TNF-\u03b1 serum levels in chronic Chagas disease patients","volume":"37","author":"Vasconcelos","year":"2015","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.jacbts.2026.101508_bib52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jacbts.2026.101508_bib53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jacbts.2026.101508_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112926","article-title":"PARP1-NFATc1-PD1 pathway of maturation and stability of CD8+T cells is beneficial against chronic Trypanosoma cruzi infection","volume":"28","author":"Chowdhury","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.jacbts.2026.101508_bib55","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1645\/GE-1757.1","article-title":"Agglutination of Trypanosoma cruzi in infected cells treated with serum from chronically infected mice","volume":"95","author":"Wendelken","year":"2009","journal-title":"J Parasitol"},{"key":"10.1016\/j.jacbts.2026.101508_bib56","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.jacc.2010.02.030","article-title":"Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic rats","volume":"55","author":"Wen","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101508_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010258","article-title":"Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB\/c mice","volume":"16","author":"Dzul-Huchim","year":"2022","journal-title":"PLoS Negl Trop Dis"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26000264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26000264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:57:23Z","timestamp":1774292243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X26000264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2452302X26000264"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101508","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RIG-I\u2013Adjuvanted Immunogen Elicited T-Cell Immunity Controls Trypanosoma cruzi, Chagasic Cardiomyopathy, and Left Ventricular Dysfunction","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101508"}}